Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants

Patrizia Della Valle, Luciano Crippa, Omid Safa, Loredana Tomassini, Elisabetta Pattarini, Silvana Vigano-D'Angelo, Maria Grazia Sabbadini, Armando D'Angelo

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Patients with antiphospholipid antibody syndrome (APS) experience a higher rate of recurrence of thrombosis than the general population of patients with thrombotic disease. Based on a retrospective analysis, it has been suggested that patients with APS should be kept on prolonged anticoagulation aiming at international normalized ratio (INR) values >3.0. To evaluate whether the requirement for more intense anticoagulation depends on the variable sensitivity of thromboplastin reagents to the influence of aPLA, we monitored oral anticoagulant treatment in 10 patients with persistent lupus anticoagulants (LA) and venous thromboembolic disease using two thromboplastin reagents : Pro-IL-Complex (Instrumentation Laboratory, combined) and Recombiplastin (Ortho, recombinant). Acenocoumarol dosage was always assigned based on INR values obtained with the combined thromboplastin using diluted (1:20) test plasma, aiming at an INR interval of 2.0 to 3.0. Single INR determinations with both reagents were obtained throughout the study period for 110 aPLA-free patients on stable oral anticoagulation. Using the manufacturer's instrument-certified international sensitivity index (ISI) values, INR obtained with the recombinant reagent were significantly higher than those obtained with the combined reagent in LA-positive patients, but they were lower in LA-negative patients. After correction for local ISI calibration in LA-negative patients, INR values of 3.1 and 4.6 with Recombiplastin corresponded, respectively, to INR values of 2.0 and 3.0 with Pro-IL-Complex. These results indicate the thromboplastin-dependency of INR values in patients with LA, thereby questioning the validity of the INR system for the monitoring of oral anticoagulant treatment in these patients.

Original languageEnglish
Pages (from-to)10-14
Number of pages5
JournalAnnales de Medecine Interne
Volume147
Issue numberSUPPL. 1
Publication statusPublished - 1996

Fingerprint

Lupus Coagulation Inhibitor
International Normalized Ratio
Thromboplastin
Antiphospholipid Syndrome
Anticoagulants
Acenocoumarol
Calibration
Thrombosis
Recurrence

ASJC Scopus subject areas

  • Medicine(all)
  • Internal Medicine

Cite this

Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants. / Della Valle, Patrizia; Crippa, Luciano; Safa, Omid; Tomassini, Loredana; Pattarini, Elisabetta; Vigano-D'Angelo, Silvana; Sabbadini, Maria Grazia; D'Angelo, Armando.

In: Annales de Medecine Interne, Vol. 147, No. SUPPL. 1, 1996, p. 10-14.

Research output: Contribution to journalArticle

Della Valle, Patrizia ; Crippa, Luciano ; Safa, Omid ; Tomassini, Loredana ; Pattarini, Elisabetta ; Vigano-D'Angelo, Silvana ; Sabbadini, Maria Grazia ; D'Angelo, Armando. / Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants. In: Annales de Medecine Interne. 1996 ; Vol. 147, No. SUPPL. 1. pp. 10-14.
@article{b74168c75c094886b01b8b44b06b5ca2,
title = "Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants",
abstract = "Patients with antiphospholipid antibody syndrome (APS) experience a higher rate of recurrence of thrombosis than the general population of patients with thrombotic disease. Based on a retrospective analysis, it has been suggested that patients with APS should be kept on prolonged anticoagulation aiming at international normalized ratio (INR) values >3.0. To evaluate whether the requirement for more intense anticoagulation depends on the variable sensitivity of thromboplastin reagents to the influence of aPLA, we monitored oral anticoagulant treatment in 10 patients with persistent lupus anticoagulants (LA) and venous thromboembolic disease using two thromboplastin reagents : Pro-IL-Complex (Instrumentation Laboratory, combined) and Recombiplastin (Ortho, recombinant). Acenocoumarol dosage was always assigned based on INR values obtained with the combined thromboplastin using diluted (1:20) test plasma, aiming at an INR interval of 2.0 to 3.0. Single INR determinations with both reagents were obtained throughout the study period for 110 aPLA-free patients on stable oral anticoagulation. Using the manufacturer's instrument-certified international sensitivity index (ISI) values, INR obtained with the recombinant reagent were significantly higher than those obtained with the combined reagent in LA-positive patients, but they were lower in LA-negative patients. After correction for local ISI calibration in LA-negative patients, INR values of 3.1 and 4.6 with Recombiplastin corresponded, respectively, to INR values of 2.0 and 3.0 with Pro-IL-Complex. These results indicate the thromboplastin-dependency of INR values in patients with LA, thereby questioning the validity of the INR system for the monitoring of oral anticoagulant treatment in these patients.",
author = "{Della Valle}, Patrizia and Luciano Crippa and Omid Safa and Loredana Tomassini and Elisabetta Pattarini and Silvana Vigano-D'Angelo and Sabbadini, {Maria Grazia} and Armando D'Angelo",
year = "1996",
language = "English",
volume = "147",
pages = "10--14",
journal = "Annales de Medecine Interne",
issn = "0003-410X",
publisher = "Masson Publishing",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants

AU - Della Valle, Patrizia

AU - Crippa, Luciano

AU - Safa, Omid

AU - Tomassini, Loredana

AU - Pattarini, Elisabetta

AU - Vigano-D'Angelo, Silvana

AU - Sabbadini, Maria Grazia

AU - D'Angelo, Armando

PY - 1996

Y1 - 1996

N2 - Patients with antiphospholipid antibody syndrome (APS) experience a higher rate of recurrence of thrombosis than the general population of patients with thrombotic disease. Based on a retrospective analysis, it has been suggested that patients with APS should be kept on prolonged anticoagulation aiming at international normalized ratio (INR) values >3.0. To evaluate whether the requirement for more intense anticoagulation depends on the variable sensitivity of thromboplastin reagents to the influence of aPLA, we monitored oral anticoagulant treatment in 10 patients with persistent lupus anticoagulants (LA) and venous thromboembolic disease using two thromboplastin reagents : Pro-IL-Complex (Instrumentation Laboratory, combined) and Recombiplastin (Ortho, recombinant). Acenocoumarol dosage was always assigned based on INR values obtained with the combined thromboplastin using diluted (1:20) test plasma, aiming at an INR interval of 2.0 to 3.0. Single INR determinations with both reagents were obtained throughout the study period for 110 aPLA-free patients on stable oral anticoagulation. Using the manufacturer's instrument-certified international sensitivity index (ISI) values, INR obtained with the recombinant reagent were significantly higher than those obtained with the combined reagent in LA-positive patients, but they were lower in LA-negative patients. After correction for local ISI calibration in LA-negative patients, INR values of 3.1 and 4.6 with Recombiplastin corresponded, respectively, to INR values of 2.0 and 3.0 with Pro-IL-Complex. These results indicate the thromboplastin-dependency of INR values in patients with LA, thereby questioning the validity of the INR system for the monitoring of oral anticoagulant treatment in these patients.

AB - Patients with antiphospholipid antibody syndrome (APS) experience a higher rate of recurrence of thrombosis than the general population of patients with thrombotic disease. Based on a retrospective analysis, it has been suggested that patients with APS should be kept on prolonged anticoagulation aiming at international normalized ratio (INR) values >3.0. To evaluate whether the requirement for more intense anticoagulation depends on the variable sensitivity of thromboplastin reagents to the influence of aPLA, we monitored oral anticoagulant treatment in 10 patients with persistent lupus anticoagulants (LA) and venous thromboembolic disease using two thromboplastin reagents : Pro-IL-Complex (Instrumentation Laboratory, combined) and Recombiplastin (Ortho, recombinant). Acenocoumarol dosage was always assigned based on INR values obtained with the combined thromboplastin using diluted (1:20) test plasma, aiming at an INR interval of 2.0 to 3.0. Single INR determinations with both reagents were obtained throughout the study period for 110 aPLA-free patients on stable oral anticoagulation. Using the manufacturer's instrument-certified international sensitivity index (ISI) values, INR obtained with the recombinant reagent were significantly higher than those obtained with the combined reagent in LA-positive patients, but they were lower in LA-negative patients. After correction for local ISI calibration in LA-negative patients, INR values of 3.1 and 4.6 with Recombiplastin corresponded, respectively, to INR values of 2.0 and 3.0 with Pro-IL-Complex. These results indicate the thromboplastin-dependency of INR values in patients with LA, thereby questioning the validity of the INR system for the monitoring of oral anticoagulant treatment in these patients.

UR - http://www.scopus.com/inward/record.url?scp=0029813875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029813875&partnerID=8YFLogxK

M3 - Article

C2 - 8952752

AN - SCOPUS:0029813875

VL - 147

SP - 10

EP - 14

JO - Annales de Medecine Interne

JF - Annales de Medecine Interne

SN - 0003-410X

IS - SUPPL. 1

ER -